
Loading, please wait...

Loading, please wait...

The rapid evolution of health technology is reshaping how we deliver healthcare globally. Specifically, the integration of AI in primary care has become a focal point for researchers, clinicians, and policymakers. A comprehensive systematic review recently evaluated over 700 publications to identify the social effects and controversies surrounding these digital tools. While the clinical potential of artificial intelligence is vast, its impact on the human side of medicine requires urgent attention.
The review identified ten primary themes that define the current landscape of medical technology. These themes include professional attitudes, patient perspectives, and the future imaginaries of automated health. Professionals often express mixed feelings about automation, citing concerns regarding job precarity and administrative shifts. Furthermore, the physician-patient relationship may undergo significant changes as AI becomes a persistent presence in the consultation room. In India, where healthcare relies heavily on trust-based interactions, these social dynamics are particularly critical for successful technology adoption.
Ethical governance and algorithmic bias remain significant hurdles for the deployment of AI in primary care. AI systems trained on non-representative data can unintentionally exacerbate health inequities among diverse or marginalized populations. Moreover, there is a clear lack of empirical studies examining artificial intelligence within routine clinical workflows. Therefore, most current evidence stems from prototype testing rather than established, long-term practice. Consequently, healthcare leaders must bridge the gap between theoretical potential and practical social impact to ensure equitable care delivery.
Algorithmic bias can worsen existing disparities if the software is trained on non-representative data. Consequently, ensuring the use of diverse datasets is essential for maintaining equity in healthcare delivery.
Most research currently focuses on technical potential rather than the complex social effects in routine clinical settings. Additionally, legal and policy frameworks often lag behind the rapid pace of technological advancements.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A systematic review identifying the social impact, ethical controversies, and professional perceptions of AI implementation within primary care settings....
4 months ago

Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today

A cross-sectional study reveals that maternal RSV vaccination coverage reached only 43.7% in Argentina, with maternal vaccine knowledge being the sole independent predictor of uptake. Clinicians play a crucial role in eliminating informational and structural barriers to optimize infant health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday